Enter Into A License Agreement For The Development And Commercialization Of An Oral Formulation
20/10/2025 24:31
Chugai Pharmaceutical Co Ltd 4519.T: CHUGAI PHARMACEUTICAL CO LTD - ENTER INTO A LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF AN ORAL FORMULATION Source text: ID:nTSvs8c635 Further company coverage: 4519.T
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)